How invisible vaccine scaffolding boosts HIV immune response Scripps Research scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.
February 05, 2026
LA JOLLA, CA One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics a virus. Then, a person's immune system produces a range of antibodies that recognize different bits of those proteins. Often, however, some of those antibodies react not to HIV itself but to the scaffold used to deliver the vaccine.
Now, researchers at Scripps Research and the Massachusetts Institute of Technology (MIT) have developed a new kind of vaccine scaffolding made from DNA that the immune system ignores, eliminating these off-target antibodies. In a new study published in Science on February 5, 2026, the team showed that vaccines made with these DNA-based scaffolds led to 10 times more immune cells targeting a vulnerable site on HIV when compared to vaccines with protein-based scaffolds. That suggests a stronger and more targeted immune response to the DNA-based vaccines.
It's a brand-new technology that might help us get to a protective HIV vaccine or solve other particularly difficult vaccine problems, says senior author Darrell Irvine, professor at Scripps Research.
Typically, a vaccine is made up of a scaffolding particle covered in many inert viral proteins (antigens) that can be recognized by the immune system. Like a virus, these vaccine structures present many copies of an antigen on their surface, triggering stronger immune activation than free-floating antigens used in previous, less effective vaccines. But until now, essentially all such scaffolds have been made from proteins, which can trigger immune reactions to the scaffolds themselves. For most vaccines targeting common pathogens, the off-target immune reaction doesn't pose major problems. But for challenging vaccine targets like HIV, influenza and pan-coronavirus vaccines where broadly protective B cells are extraordinarily rare every competing immune response could matter.
We knew that protein nanoparticle scaffolds generate their own immune responses, but we didnt know how much those off-target responses were actually limiting the immune cells we care about, says Irvine, who is also a Howard Hughes Medical Institute Investigator.
In the new work, Irvine, along with lead author Anna Romanov and collaborators including biological engineer Mark Bathe of MIT, turned to DNA origami technology, which allows scientists to fold DNA into precise three-dimensional shapes. There's limited data regarding the use of DNA origami in vaccines, but the researchers already knew that B cells the immune cells responsible for recognizing antigens and producing antibodies don't flag DNA. That's in part to protect people from autoimmune reactions attacking their own DNA.
In prior work in 2024 using a SARS-CoV-2 antigen, we found DNA scaffolds were silent' immunologically without generating an antibody response, but it was unclear whether they'd also promote focused germinal center responses; this study now clearly demonstrates this response for Scripps' HIV antigen, which is a breakthrough for the active immunotherapy field, says Bathe.
The team designed DNA nanoparticles that could each display 60 copies of an HIV envelope protein one that's known to activate the rare B cells that can eventually produce broadly neutralizing antibodies against HIV. They then tested the nanoparticles in mice expressing human antibody genes. Nearly 60% of the germinal center B cells specialized immune cells that mature to produce the high-quality antibodies targeted the HIV envelope protein. By contrast, the protein-scaffolded vaccine (which is currently in clinical trials) generated germinal centers where only about 20% of B cells recognized the HIV target; the rest included many cells responding to the scaffold itself.
The DNA-based vaccine achieved a 25-fold better ratio of HIV-specific to off-target immune cells compared to the protein scaffold. Within two weeks of vaccination, mice who had received the DNA-based vaccine had detectable levels of the desired rare B cells, while mice who had received the protein nanoparticle-based vaccine had none of the cells detectable.
The implications extend beyond HIV, as the same challenges apply to efforts to develop universal influenza and pan-coronavirus vaccines. DNA origami scaffolds could provide a more focused immune response for any of these challenging vaccine problems, says Irvine.
These are vaccines where you're trying to recruit incredibly rare cells in the B-cell repertoire, he adds. Anything that limits those correct cells from getting activated is a potential problem, and DNA origami scaffolds could help overcome these challenges.
The Irvine and Bathe teams are now studying how variations in the shape of the DNA origami may impact vaccine effectiveness, as well as testing the long-term safety of the scaffolds for vaccination.
In addition to Irvine and Bathe, authors of the study, DNA origami vaccines program antigen-focused germinal centers, include Christopher Cottrell, Heikyung Suh, Asheley Chapman, Patrick Skog, Claudia Finn, Jeong Hyun Lee, Oleksandr Kalyuzhniy, Alessia Liguori, Ryan Tingle, Torben Schiffner and William Schief of Scripps Research; Anna Romanov, Grant Knappe, Larance Ronsard, Yiming Zhang, Lauren Duhamel, Marjan Omer, Katie Spivakovsky, Molly Parsons, Vanessa Lewis and Daniel Lingwood of MIT; and Josue Canales and Boris Reizis of New York University Grossman School of Medicine.
This work was supported by funding from the National Institutes of Health
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
02/05/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
01/05/2026
January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...
01/04/2026
January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION
Douyin Users Can Now Create And Share Videos With Stun...
05/03/2026
Quality control (QC) has long been a gatekeeper of technical fidelity. Editors and technicians have adhered to a simple, disciplined checklist: bitrate, resolut...
05/03/2026
Leading video software provider Synamedia today announced it has partnered with Swiss sports technology specialist, Asport to deliver global live streaming for ...
05/03/2026
Advanced Systems Group, LLC (ASG), a technology and services provider for media creatives and content owners, announced the promotion of Gretchen Taipale to Vic...
05/03/2026
Clear-Com has provided Gen-IC virtual intercom, its cloud-based voice communications system for SaxaVord Spaceport, the first fully licensed vertical launch s...
05/03/2026
The Hollywood Professional Association (HPA) concluded the 2026 HPA Tech Retreat, convening more than 800 industry leaders, technologists, creatives and executi...
05/03/2026
LynTec, a leading manufacturer of electrical power control solutions for professional audio, video, and lighting systems, today announced that its new Dual DMX ...
05/03/2026
Snicket Labs is pleased to announce a new distribution partnership with ES Broadcast for its award winning solutions, Match and Enrich.
Under the agreement, ES...
05/03/2026
LiveU today announced the first large-scale deployment of its AI-driven LiveU IQ (LIQ ) technology at a global, multi-venue sporting event, setting a new benchm...
05/03/2026
March is in full bloom, and that means a fresh wave of games heading to the cloud. 15 new titles are joining the GeForce NOW library this month.
Leading the Ma...
04/03/2026
Lega Basket Serie A (LBA), the governing body for Italy's premier basketball...
04/03/2026
Wrexham AFC co-chairmen Rob Mac and Ryan Reynolds will host a first-of-its-kind ...
04/03/2026
The countdown is underway and with just 100 days to go until the world's greatest sporting event begins on Thurs., June 11, FOX Sports, America's Englis...
04/03/2026
No matter where they are in the world, service members and veterans can stream N...
04/03/2026
Telemundo officially releases Somos M s, the anthem for the network's cove...
04/03/2026
The Hollywood Professional Association (HPA) concluded the 2026 HPA Tech Retreat, convening more than 800 industry leaders, technologists, creatives, and execut...
04/03/2026
Smith Entertainment Group transformed how local sports are consumed by creating ...
04/03/2026
The production method, which spans a distance of 36.2 miles, was designed and im...
04/03/2026
Haivision, a global provider of mission-critical, real-time video networking and...
04/03/2026
When Hugues Meyrath came out of retirement to take the helm as CEO of Quantum, i...
04/03/2026
Last week's launch of Banana Ball Championship League has spurred a significant upgrade of production facilities
The Savannah Bananas, arguably the hottest...
04/03/2026
sldkfjsdlfkjsldkfjsldkjfslkdjfslkdjfsl
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus...
04/03/2026
For many fans, a song's backstory can be just as compelling as the final pro...
04/03/2026
In 2006, Spotify was founded on the belief that technology could bring artists a...
04/03/2026
Spotify is back on the ground for the Houston Livestock Show and Rodeo, and we&#...
04/03/2026
Spotify had an energizing week in Sydney, Australia, filled with powerful conver...
04/03/2026
Earlier this year, we launched Directed By, a documentary-style series that pull...
04/03/2026
100 Days to Go: SBS Unveils World Class Team for The Greatest Show on Earth -The...
04/03/2026
KT and Rohde & Schwarz to showcase AI-enhanced radio transmission performance In a joint 6G AI proof-of-concept demonstration, the CMX500 one-box tester from ...
04/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/03/2026
Luxembourg, 3 March 2026 - SES S.A. has today published its 2025 Annual Report, following the announcement of the company's full year financial results for ...
04/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/03/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
04/03/2026
Luxembourg, March 3, 2026 - SES, a leading space solutions company, along with I...
04/03/2026
04 Mar 2026
VEON Partners with GSMA Innovation Fund to Accelerate Digital Innov...
04/03/2026
04 Mar 2026
VEON's Beeline Uzbekistan and Rakuten Symphony Partner for Open...
04/03/2026
Wednesday 4 March 2026
Sky Sports unveils plans for 2026 Formula 1 coverage
Sky Sports is preparing for one of the most highly anticipated F1 seasons in recen...
04/03/2026
Back to All News
Bloodhounds' Season 2 Gears Up for April 3 Premiere with ...
04/03/2026
Back to All News
Netflix Ads Suite Expands Capabilities
Business
04 March 2026
GlobalUnited States
Link copied to clipboard
After launching the Netflix Ad...
04/03/2026
Scripps Research welcomes healthcare innovator Joe Kiani to the Board of Directors Kiani brings decades of experience in patient safety and public service.
Mar...
04/03/2026
Nanoparticle vaccine approach takes on a new target: Hepatitis C virus Scripps Research scientists reengineer critical proteins on the surface of HCV, paving th...
03/03/2026
Beyond Sports, a Sony group company, and LIV Golf, the world's golf league, ...
03/03/2026
Ilitch Sports + Entertainment announces the launch of Detroit SportsNet (DSN), a year-round broadcast home for two of Detroit's franchises. With flexible op...
03/03/2026
Advanced Systems Group, LLC (ASG), a technology and services provider for media ...
03/03/2026
The PGA of America, NBC Sports and USA Sports extend their media rights agreemen...
How invisible vaccine scaffolding boosts HIV immune response Scripps Research scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.
